Risk of financial catastrophe for breast cancer patients in Nigeria: A retrospective analysis.

Am J Surg

Department of Surgery, Northwestern University Feinberg School of Medicine Chicago IL, USA; Havey Institute of Global Health, Northwestern University, Chicago, IL, USA; Institute for Public Health and Medicine, Northwestern University, Chicago, IL, USA.

Published: January 2025

Introduction: Cancer imposes significant financial burden on patients in low and middle-income countries like Nigeria, where breast cancer (BC) is the most common cancer and has the highest mortality. This study aims to investigate the financial burden of BC care at Lakeshore Cancer Center (LCC) in Nigeria and identify risk factors for financial catastrophe (FC).

Methods: LCC was queried for uninsured patients diagnosed with breast cancers between 2013 and 2023, linked to cost data through chart abstraction of billing data and adjusted to 2023 USD. All costs were out-of-pocket costs (OOP) as all patients were uninsured. Risk for financial catastrophe was defined as OOP exceeding 20 ​% of Nigeria's 2023 per capita GDP ($467). Total OOP and risk for financial catastrophe were measured with descriptive statistics and stratified by clinical characteristics.

Results: 352 BC patients (99 ​% female, median age 47, 41 ​% stage 4, 28 ​% stage 3) were included. 260 (74 ​%) patients risked financial catastrophe, despite only 30 ​% completing treatment. Patients with HER2+/HR ​+ ​disease exhibited the highest treatment costs. Among patients that underwent multiple treatment modalities (n ​= ​130), the average OOP was $17992 with 100 ​% risking financial catastrophe. The highest contributors to the cohort's total costs were chemotherapy (29 ​%), immunotherapy (18 ​%), and other drugs (12 ​%). Surgery contributed 7 ​%.

Discussion: Less than one-third of BC patients completed treatment, and the majority faced financial catastrophe, especially those with HER2+/HR ​+ ​disease and patients who underwent multiple treatment modalities or immunotherapy. Targeted efforts are essential to ensure equitable access to quality cancer care while minimizing risk of financial catastrophe.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2024.116053DOI Listing

Publication Analysis

Top Keywords

financial catastrophe
32
risk financial
16
patients
10
financial
9
catastrophe
8
breast cancer
8
financial burden
8
patients underwent
8
underwent multiple
8
multiple treatment
8

Similar Publications

Timely damage detection on a mechanical system can prevent the appearance of catastrophic damage in it, as well as allow for better scheduling of its maintenance and repair process. For this purpose, multiple signal analysis methods have been developed to help identify anomalies in a system, through quantities such as vibrations or deformations in its critical components. In most applications, however, these data may be scarce or inexistent, hindering the overall process.

View Article and Find Full Text PDF

Purpose: Financial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from high-income countries, which may not apply to LMICs. The causes and consequences of FT in patients with cancer in LMICs remain understudied.

Methods: Following PRISMA guidelines, we searched MEDLINE, Web of Science, and CINAHL for FT literature in cancer originating from LMICs from inception until the end of 2023, and documented the different definitions used to define FT in LMICs, and the magnitude of FT documented using those definitions.

View Article and Find Full Text PDF

Background: Financial toxicity is the detrimental impact of health care costs that must be mitigated to achieve universal health coverage. Catastrophic health expenditure (CHE) is widely used to measure financial toxicity but does not capture patient perspectives of unaffordable health care costs. Financial hardship (FH), a patient-reported outcome measure, is currently underutilized but may be an important adjunct metric.

View Article and Find Full Text PDF

Background: Medicare Part D covers outpatient prescription drugs for elderly beneficiaries, but requires full cost coverage once the coverage gap threshold is reached. We assessed the impact of reaching Medicare Part D threshold on out-of-pocket costs (OOP), timely treatment, and outcomes for patients with gastrointestinal (GI) cancer.

Methods: Individuals newly diagnosed with GI cancer between 2007 and 2019 were identified from the SEER-Medicare database.

View Article and Find Full Text PDF

Background: Seasonal influenza illness and acute respiratory infections can impose a substantial economic burden in low- and middle-income countries (LMICs). We assessed the cost of influenza illness and acute respiratory infections across household income strata.

Methods: We conducted a secondary analysis of data from a prior systematic review of costs of influenza and other respiratory illnesses in LMICs and contacted authors to obtain data on cost of illness (COI) for laboratory-confirmed influenza-like illness and acute respiratory infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!